Clinical trial
Combination Chemotherapy in Treating Patients With Recurrent or Metastatic…
NCT00003001 · Stony Brook University, Other · Unknown status
Key facts
| NCT number | NCT00003001 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer |
| Official title | Phase I/II Study of 5-Fluorouracil/Folinic Acid/Gemcitabine in Patients With Advanced Colorectal Carcinoma |
| Lead sponsor | Stony Brook University, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | fluorouracil, gemcitabine hydrochloride, leucovorin calcium |
| Enrollment | 63 |
| Start date | Apr 1, 1997 |
| First posted | Apr 29, 2004 |
| Last update posted | Jul 24, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: